Mankind Pharma

Jefferies buy recommendations, Reliance Industries target price, JSW Energy stock, HDFC Bank share outlook, IndusInd Bank target

Jefferies’ September shopping list: M&M, Sun Pharma & 3 more stocks set to rally – Do you own them?

Jefferies names M&M, TVS Motor, Jindal Stainless, Sun Pharma, and Mankind Pharma as top September buys—see why these stocks could…

September 15, 2025 11:15 IST

From Adani Enterprises, Maruti Suzuki, Coal India to Dabur India – Here are 10 stocks to watch

Stocks to watch today, August 01: GIFT Nifty indicates a lower start for domestic indices. Here are the top stocks…

August 1, 2025 06:46 IST

Trump tariff on India, pharma sector impact, Indian pharma exports

Trump tariff impact on Pharma: Breathing easy or trapped in crosshair ahead? Here’s how stocks are reacting

Trump’s new tariffs spark uncertainty for India’s pharma exports and stocks; check out how the sector is reacting and what…

July 31, 2025 10:59 IST

midday stock movers, MRF share price, PN Gadgil Jewellers Q1 results

Stocks making the biggest moves midday: HCL Tech, HUL, Vedanta, Phoenix Mills and more

Track midday stock movers like HCL Tech, Tata Steel, Mankind Pharma, and Vedanta; review key market catalysts and analyst insights…

July 9, 2025 14:05 IST

Empagliflozin, Empagliflozin generics, Empagliflozin Mankind Pharma, Rajeev Juneja, Glenmark Pharma, Alkem Labs, healthcare news, pharma news,

Mankind to sell its diabetes drug, Empagliflozin, for Rs 5, company expects 50% volume growth: Rajeev Juneja

On Wednesday, Glenmark and Alkem Labs launched the generic version as well as its Fixed Dose Combination (FDCs) of Empagliflozin…

March 12, 2025 13:56 IST

Boehringer Ingelheim, Boehringer Ingelheim India, Boehringer Ingelheim diabetes, Empagliflozin, Empagliflozin in India, patent loss, healthcare news pharma news,

Boehringer Ingelheim’s blockbuster diabetes drug goes off patent today—Will it lower treatment costs in India?

Empagliflozin is a SGLT-2 inhibitor and it has shown to significantly reduce the progression of kidney disease and heart failure.

March 11, 2025 10:51 IST

Mankind Pharma transfers OTC Business to subsidiary Mankind Consumer Products Private Limited

Q3FY25: Mankind Pharma’s revenue up by 24 percent to Rs 3,230 Crore; Profit at Rs 380 crore

The integration of BSV is on track, with focus on mandate brands, improving productivity and adopting best practices to ensure…

January 23, 2025 19:39 IST

Q2FY25: Mankind Pharma’s profit jumps 29 percent to Rs 658.88 crore; Revenue up 13.6% to Rs 3,076.51 crore

During the quarter, we have launched 1 new product in US taking the total launched products to 42.

November 5, 2024 17:23 IST

Mankind Pharma acquires BSV to expand its portfolio in women’s health and fertility drug market

According to the company’s statement, Mankind Pharma may consider to retire, a portion of the debt through a potential equity…

October 24, 2024 11:34 IST

Mankind Pharma transfers OTC Business to subsidiary Mankind Consumer Products Private Limited

Mankind Pharma’s consumer products portfolio includes several trusted brands Manforce, HealthOK, Prega News, AcneStar, Unwanted and Gas-O-Fast across categories such…

October 1, 2024 13:57 IST

Mankind Pharma, Mankind Pharma condom, Mankind Pharma owners, Mankind Pharma revneue, Juneja, Juneja brothers, Juneja net worth, Mankind Pharma companies, condom brands in india, lifestyle

Meet Juneja Brothers: How they built Rs 95,876 crore Mankind Pharma, India’s fourth largest pharma company

Mankind Pharma was founded in 1995 by Ramesh Juneja and his younger brother Rajeev Juneja, marking the beginning of a…

Updated: September 9, 2024 10:27 IST

Mankind Pharma signs agreement with Takeda to commercialise novel drug for GERD treatment in India

Mankind Pharma announces entry into topical analgesic market, launches Nimulid Strong

Nimulid Strong will be available in both gel and spray variants, offering consumers flexibility in application, the company stated.

September 2, 2024 17:24 IST

Mankind Pharma, Mankind Pharma Q1 results, quarter earnings, profit, revenue, exports, domestic business, Pharmaceutical industry

Mankind Pharma Q1 Results: Profit rises by 10.2% to Rs 536.49 crore, revenue at Rs 2,893.42 crore

Mankind Pharma recorded revenue from operations at Rs 2,893.42 crore, up 12.2 per cent as against Rs 2,578.62 crore during…

July 31, 2024 15:58 IST

Mankind Pharma, BSV, Mankind Pharma acquisition, BSV news, healthcare news, pharma news,

Mankind Pharma to acquire 100 percent stake in BSV; Plans to expand high entry barrier portfolio

BSV reported revenues of INR 1,723 crore in FY24, delivering robust 20% y-o-y growth with adjusted EBITDA Margins of 28%.…

July 26, 2024 10:48 IST

Mankind Pharma, Q3, top news, latest news, business news,

Mankind Pharma to sell its OTC business on slump sale basis

Some of the key OTC products by Mankind Pharma include the anti-inflammatory and anti-bacterial product AcneStar, the HealthOk multivitamin tablets,…

April 3, 2024 12:59 IST

ChrysCapital pares 2.9 per cent stake in Mankind Pharma for Rs 2,469 crore

According to the bulk deal data available on the NSE, Beige Ltd offloaded more than 1.16 crore shares, amounting to…

March 26, 2024 21:25 IST

Mankind Pharma beats Q3 profit estimates on strong demand

Mankind Pharma, one of India’s leading condom makers, posted a bigger-than-expected rise in third-quarter profit on Wednesday.

January 31, 2024 19:10 IST

Diwali Special: Top 10 IPOs that sparkled from last Diwali to this Diwali

56 companies that went public since Diwali 2022, collectively raising a staggering Rs 47,890 crore from the primary market,

Updated: November 10, 2023 11:39 IST

Related News

F-1 visa denied for applicant after single question at US Consulate

Techie discusses move back to India amid Green Card concerns.

Techie plans return to India after 15 years in US amid green card uncertainty, says ‘want to move before…’

WinTrack highlighted a case of an entrepreneur allegedly harassed by customs at Indira Gandhi International Airport in Delhi, stressing that “genuine entrepreneurs face harassment frequently”.

‘Reccuring problem at Indian airports’: Wintrack highlights case of entrepreneur harassed by customs at Delhi Airport

Aadhaar rule change 2025: New UIDAI update fees, PAN-Aadhaar link and KYC rules explained

Aadhaar rule change 2025: New UIDAI update fees, PAN-Aadhaar linking and KYC rules explained

Trump threatens 'fast, furious and brutal' end to Hamas, says US allies ready to visit Gaza with 'heavy force'

Green card program targeted in proposed employment-based visa update

Consumer sector sees surge in CEO transitions

Business5 hr ago

In India, the consumer sector is witnessing a major change in leadership, with 1 in 3 CEOs switching roles in the last 3 years. 57% of these leaders moved from multinational corporations to Indian firms, driven by generational changes and increasing trust in local brands. Indian companies are also offering competitive compensation, making them attractive for global talent.

View all shorts